The effectiveness of cerebrolysin, a multi-modal neurotrophic factor, for treatment of post-covid-19 persistent olfactory, gustatory and trigeminal chemosensory dysfunctions: a randomized clinical trial-Reference-Cited by-同舟云学术

The effectiveness of cerebrolysin, a multi-modal neurotrophic factor, for treatment of post-covid-19 persistent olfactory, gustatory and trigeminal chemosensory dysfunctions: a randomized clinical trial

Published:2023-11-21 Issue:12 Volume:16 Page:1261-1276
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Hamed Sherifa Ahmed¹,Ahmed Mohamed Azzam Abdel-Razek²

Affiliation:

1. Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt

2. Department of ENT, Assiut University Hospital, Assiut, Egypt

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2282715

Reference52 articles.

1. Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients’ Reports on Social Media

2. Long COVID in a prospective cohort of home-isolated patients

3. COVID ‐19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste

4. The COVOSMIA-19 trial: Preliminary application of the Singapore smell and taste test to objectively measure smell and taste function with COVID-19

5. Changes in smell and taste perception related to COVID-19 infection: a case–control study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia;Biomedicines;2024-09-12

2. A Comprehensive Review of COVID-19-Related Olfactory Deficiency: Unraveling Associations with Neurocognitive Disorders and Magnetic Resonance Imaging Findings;Diagnostics;2024-02-07